The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Adial Pharmaceuticals Inc (NASDAQ: ADIL) closed at $0.67 in the last session, down -14.10% from day before closing price of $0.78. In other words, the price has decreased by -$14.10 from its previous closing price. On the day, 23.63 million shares were traded. ADIL stock price reached its highest trading level at $1.21 during the session, while it also had its lowest trading level at $0.6308.
Ratios:
We take a closer look at ADIL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.16 and its Current Ratio is at 4.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On October 30, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADIL now has a Market Capitalization of 4404975 and an Enterprise Value of 654448.
Stock Price History:
The Beta on a monthly basis for ADIL is 1.19, which has changed by -0.5889571 over the last 52 weeks, in comparison to a change of 0.09765589 over the same period for the S&P500. Over the past 52 weeks, ADIL has reached a high of $3.00, while it has fallen to a 52-week low of $0.58. The 50-Day Moving Average of the stock is -6.64%, while the 200-Day Moving Average is calculated to be -28.33%.
Shares Statistics:
According to the various share statistics, ADIL traded on average about 888.24K shares per day over the past 3-months and 3095300 shares per day over the past 10 days. A total of 6.47M shares are outstanding, with a floating share count of 6.46M. Insiders hold about 1.73% of the company’s shares, while institutions hold 9.17% stake in the company. Shares short for ADIL as of 1744675200 were 217057 with a Short Ratio of 0.24, compared to 1741910400 on 549373. Therefore, it implies a Short% of Shares Outstanding of 217057 and a Short% of Float of 3.35.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Adial Pharmaceuticals Inc (ADIL) reflects the collective analysis of 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.28 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$1.22 and -$2.7 for the fiscal current year, implying an average EPS of -$1.75. EPS for the following year is -$1.18, with 2.0 analysts recommending between -$1.0 and -$1.37.
